Profitability
This table compares BioLargo and its rivals’ net margins, return on equity, and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioLargo | -16.53% | -58.35% | -32.12% |
| BioLargo Competitors | -568.74% | 5.73% | -0.15% |
Analyst Ratings
This is a breakdown of recent ratings and price targets for BioLargo and its rivals by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioLargo | 0 | 0 | 0 | 0 | N/A |
| BioLargo Competitors | 139 | 1275 | 1591 | 46 | 2.51 |
Chemicals & allied products companies have a potential upside of 5.11%. Analysts believe BioLargo has less growth potential compared to its rivals.
Risk & Volatility
BioLargo has low volatility with a beta of 0.2, while its rivals have a beta of 1.78, indicating higher volatility.
Institutional and Insider Ownership
0.0% of BioLargo shares are held by institutional investors, while its industry average is 68.4%. Company insiders hold 20.3% of BioLargo shares.
Valuation & Earnings
This table compares BioLargo and its rivals’ revenue, earnings per share, and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| BioLargo | $12.23M | -$3.50M | -7.81 |
| BioLargo Competitors | $6.64B | $206.77M | 66.83 |
BioLargo’s rivals have higher revenue and earnings. BioLargo’s stock is more affordable based on its price-to-earnings ratio.
Summary
BioLargo’s rivals outperform on 8 of the 10 factors compared.
About BioLargo
BioLargo, Inc. develops platform technologies to solve environmental problems. It offers services in various environmental areas and was incorporated in 1991, based in Westminster, California.
Receive News & Ratings for BioLargo Daily – Enter your email below to receive a summary of news and analysts’ ratings for BioLargo and related companies with MarketBeat.com’s FREE email newsletter.
